Abstract
1. In oesophageal smooth muscle strips from spontaneously hypertensive rats (SHR) of 8-10 and 22-24 weeks of age, respectively, beta-adrenoceptor-mediated relaxation was investigated, by use of the beta-agonists, (-)-isoprenaline and fenoterol (both in the absence and presence of the beta 2-selective antagonist ICI 118,551) and the selective beta 3-agonist, BRL 37,344. 2. In preparations from 8-10 week SHR, (-)-isoprenaline- and fenoterol-induced concentration-response curves (CRCs) were hardly antagonized by ICI 118,551 at concentrations up to 1 microM, indicating only a minor contribution of beta 2-adrenoceptors. pA2-values for ICI 118,551 of 5.30 ((-)-isoprenaline as agonist) and 5.46 (fenoterol as agonist), estimated from the shifts at the highest (10-100 microM) antagonist concentrations, are consistent with affinity at a beta 3-adrenoceptor, similar to that in Wistar rat oesophageal smooth muscle. 3. In 8-10 week SHR, adrenodemedullated at 4 weeks of age (SHR-ADM4) the potency of fenoterol was markedly increased and CRCs were shallow. In addition, ICI 118,551 (0.1 microM) now produced a clear rightward shift accompanied by a steepening of the CRC. A marked further shift was observed only at 100 microM of the antagonist. T...Continue Reading
References
May 1, 1978·The Journal of Pharmacy and Pharmacology·D MacKay
Feb 1, 1979·Biochimica Et Biophysica Acta·C J Limas, C Limas
Nov 20, 1975·Nature·G GrobeckerI J Kopin
Jan 1, 1992·Endocrinology·J G Granneman, K N Lahners
Feb 11, 1992·European Journal of Pharmacology·R RemieJ Zaagsma
Dec 1, 1992·Journal of Autonomic Pharmacology·K R BorkowskiH Schneider
May 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·R F ThomasS B Liggett
Mar 1, 1991·Biochemical Pharmacology·L J EmorineD A Strosberg
Feb 1, 1991·Journal of Autonomic Pharmacology·K R Borkowski
Aug 1, 1990·Hypertension·M C MichelP A Insel
Jul 1, 1989·Hypertension·T Hano, J Rho
Aug 1, 1987·Canadian Journal of Physiology and Pharmacology·R D Feldman
Jun 1, 1985·Journal of Autonomic Pharmacology·K R Borkowski, P Quinn
Nov 1, 1988·British Journal of Pharmacology·R A Bond, D E Clarke
Jan 13, 1986·Life Sciences·H A Struyker-BoudierH H Thijssen
Mar 1, 1987·Journal of Autonomic Pharmacology·M C MichelO E Brodde
Mar 1, 1984·Journal of Autonomic Pharmacology·K R Borkowski, M Porter
Jan 1, 1984·Blood Vessels·C B Toal, F H Leenen
Nov 1, 1983·British Journal of Pharmacology·K R Borkowski, P Quinn
Jun 1, 1994·Journal of Cardiovascular Pharmacology·M BöhmE Erdmann
Apr 1, 1995·Clinical and Experimental Hypertension : CHE·A CasesL Revert
Oct 1, 1994·British Journal of Pharmacology·R P CoppesJ Zaagsma
Sep 1, 1993·British Journal of Pharmacology·R E de BoerJ Zaagsma
Apr 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·S B LiggettR J Lefkowitz
Aug 1, 1993·Hypertension·M C MichelO E Brodde
Oct 1, 1995·British Journal of Pharmacology·R E de BoerJ Zaagsma
Mar 1, 1959·British Journal of Pharmacology and Chemotherapy·O ARUNLAKSHANA, H O SCHILD
May 1, 1961·Circulation Research·A E DOYLE, J R FRASER
Mar 1, 1963·Japanese Circulation Journal·K OKAMOTO, K AOKI